missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ West Nile Virus Envelope Synthetic Peptide
Click to view available options
Quantité:
50 μg
Conditionnement:
50µg
Description
West Nile Virus Envelope Synthetic Peptide, PEP-0222, from Invitrogen.
West Nile Virus (WNV) is a member of the Flaviviridae, a plus-stranded virus family that includes St. Louis encephalitis virus, yellow fever virus, and Dengue virus. WNV was initially isolated in 1937 in the West Nile region of Uganda and has become prevalent in Africa, Asia, and Europe. It has rapidly spread across the United States with cases being observed in every continental state. Virus particles consist of a dense core made up of the core/capsid protein encapsulating the RNA genome surrounded by a membrane envelope embedded with envelope and matrix proteins which play a major role for WNV entry into target cells. The viral core protein is thought to contribute to the WNV-associated inflammation via apoptosis induced though the caspase-9 pathway as delivery of core gene delivery into the striatum of mouse brain and skeletal muscle resulted in cell death and inflammation.
Spécification
Spécification
| Espèces | Virus |
| Méthode de purification | purified |
| Nom usuel | West Nile Virus Envelope |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Lyophilisé | No |
| Afficher plus |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu